RU2019144196A3 - - Google Patents

Download PDF

Info

Publication number
RU2019144196A3
RU2019144196A3 RU2019144196A RU2019144196A RU2019144196A3 RU 2019144196 A3 RU2019144196 A3 RU 2019144196A3 RU 2019144196 A RU2019144196 A RU 2019144196A RU 2019144196 A RU2019144196 A RU 2019144196A RU 2019144196 A3 RU2019144196 A3 RU 2019144196A3
Authority
RU
Russia
Application number
RU2019144196A
Other languages
Russian (ru)
Other versions
RU2019144196A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019144196A publication Critical patent/RU2019144196A/ru
Publication of RU2019144196A3 publication Critical patent/RU2019144196A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2019144196A 2018-02-21 2019-02-12 Фармацевтическая композиция, содержащая ремоглифлозин и противодиабетическое средство RU2019144196A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201821006578 2018-02-21
IN201821006578 2018-02-21
PCT/IB2019/051116 WO2019162800A1 (en) 2018-02-21 2019-02-12 Pharmacutical composition comprising remogliflozin and antidiabetic agent

Publications (2)

Publication Number Publication Date
RU2019144196A RU2019144196A (ru) 2021-06-28
RU2019144196A3 true RU2019144196A3 (es) 2021-06-28

Family

ID=67687425

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019144196A RU2019144196A (ru) 2018-02-21 2019-02-12 Фармацевтическая композиция, содержащая ремоглифлозин и противодиабетическое средство

Country Status (7)

Country Link
KR (1) KR20200035437A (es)
CN (1) CN111246917A (es)
BR (1) BR112020017056A2 (es)
MX (1) MX2020008546A (es)
PH (1) PH12020500228A1 (es)
RU (1) RU2019144196A (es)
WO (1) WO2019162800A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111588713B (zh) * 2020-06-22 2021-03-09 广州市力鑫药业有限公司 一种治疗糖尿病的药物组合物及其制备方法
WO2022263935A1 (en) * 2021-06-14 2022-12-22 Glenmark Pharmaceutical Limited Pharmacutical composition comprising remogliflozin etabonate, metformin hydrochloride and vildagliptin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010045656A2 (en) * 2008-10-17 2010-04-22 Nectid, Inc. Novel sglt2 inhibitor dosage forms
BR112012011733A2 (pt) * 2009-11-13 2019-09-24 Bristol-Myers Squibb Company formulações de comprimido de liberação imediata
CN104586834A (zh) * 2014-12-12 2015-05-06 周连才 一种艾帕列净和二甲双胍的药物组合物及其制备方法
CN110753540A (zh) * 2017-06-08 2020-02-04 格兰马克药品有限公司 瑞格列净的口服药物制剂

Also Published As

Publication number Publication date
RU2019144196A (ru) 2021-06-28
CN111246917A (zh) 2020-06-05
WO2019162800A1 (en) 2019-08-29
KR20200035437A (ko) 2020-04-03
BR112020017056A2 (pt) 2020-12-15
PH12020500228A1 (en) 2020-11-09
MX2020008546A (es) 2021-01-08

Similar Documents

Publication Publication Date Title
BR112021012222A2 (es)
BR122022006221A2 (es)
BR122022015534A2 (es)
BR112021008873A2 (es)
BR122022002075A2 (es)
AT524834A2 (es)
AT524874A5 (es)
AU2018438767B1 (es)
RU2019144196A3 (es)
AT521543A3 (es)
AT524961A5 (es)
AT524266A2 (es)
BR122022005529A2 (es)
BR122022016585A2 (es)
BR112020012832A2 (es)
BR102018070765A2 (es)
BR102018016915A2 (es)
BE2018C025I2 (es)
BR112020025288A2 (es)
BR102018007062A2 (es)
BR202018006247U2 (es)
BR202018004136U2 (es)
BR202018002487U2 (es)
BR202018002069U2 (es)
CN304453979S (es)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20210802